SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Oxford GlycoSciences Plc
An SI Board Since January 2000
Posts SubjectMarks Bans
469 13 0
Emcee:  Jongmans Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
194OXFORD, UK, March 7 /PRNewswire-FirstCall/ -- Oxford GlycoSciences Plc (LSE: OGSnigel bates-3/7/2002
193OGS Building a Sustainable Pipeline: New Programmes and New Clinical Trials OXFnigel bates-3/7/2002
192Announced today that OGS will drop out of the FTSE 250 index. With any luck, thinigel bates-3/6/2002
191(FWIW) A Discussion of OGS' Integrated Pipeline Development Strategies Oxfnigel bates-3/1/2002
190Confirmant Unveils the First Comprehensive Database of Human Proteins, Their Varnigel bates-2/25/2002
189GeneProt Licences OGS' Automated Proteomics Patents OXFORD, UK, and NORTH Bnigel bates-2/8/2002
188(OT a bit) I'm not sure that these sugar stories are really that relevant tnigel bates-1/21/2002
187OXFORD, England, PRINCETON, N.J. and COPENHAGEN, Denmark, Jan. 9/PRNewswire/ -- nigel bates-1/9/2002
186Thanks tuck. My internet access will be severely limited for the next couple ofnigel bates-12/15/2001
185>>OXFORD, UK, Dec. 14 /PRNewswire/ -- Oxford GlycoSciences Plc (LSE: OGS; tuck-12/14/2001
184Yahoo price & volume details need to be taken with a pinch of salt for OGS, nigel bates-12/11/2001
183atugen AG announces target validation collaboration with Oxford GlycoSciences nigel bates-12/11/2001
182The PR itself - Oxford, UK, 7 December 2001 - Oxford GlycoSciences Plc (LSE: OGnigel bates-12/7/2001
181Oxford Glyco claims world lead with 4,000 proteins LONDON, Dec 7 (Reuters) - Oxnigel bates-12/7/2001
180(FWIW) From FT Biotech survey - <i>http://news.ft.com/ft/gx.cgi/ftc?pagennigel bates-11/28/2001
179Teva partners OGS drug in key Israel market LONDON, Nov 20 (Reuters) - Oxford Gnigel bates-11/20/2001
178MACCABIM, Israel, Nov. 6 /PRNewswire/ -- Glycominds Ltd. today announced the sucnigel bates-11/6/2001
177Got a few more myself this morning. The spread on this stock is criminal. Still,nigel bates-10/30/2001
176I doubled my position today. Cheers, Tucktuck-10/30/2001
175I never thought I'd see this one trading at cash, but it's not that far nigel bates-10/29/2001
174FDA Accepts Vevesca File.. uk.biz.yahoo.com martinJongmans-10/17/2001
173Interesting. The Glycominds' "Glycochip" should be right up your snigel bates-10/16/2001
172Believe this relates somewhat to OGSI: bio.com Cheers, Tucktuck-10/16/2001
171If the "T-12" programme delivers on hype, the first OGS Mab candidate keokalani'nui-10/15/2001
170Nigel, Nice dig. Tips me further in the direction of nibbling a little more intuck-10/14/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News